Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40014894
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
18/12/2025
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target: Waters Corporation commits to achieve net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Waters Corporation commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by 2030 from a 2024 base year.* Waters Corporation also commits to reduce scope 3 GHG emissions from use of sold products 51.6% per USD value added within the same timeframe. Waters Corporation further commits that 52% of its suppliers by spend covering purchased goods and services, will have science-based targets by 2030. Long-Term Targets: Waters Corporation commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by 2050 from a 2024 base year.* Waters Corporation also commits to reduce scope 3 GHG emissions from purchased goods and services, upstream transportation and distribution and use of sold products 97.0% per USD value added within the same timeframe. *The target boundary includes land-related emissions and removals from biogenic feedstocks.
Statut
Targets setAnnée cible
2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
US9418481035
LEI
5T547R1474YC9HOD8Q74
Source : Science Based Targets initiative | Données publiques